TRex Bio IPO priced at $14, to start trading Friday
Clinical-stage biotech TRex Bio priced its IPO at $14 per share, raising about $116.7 million, and will begin trading on Nasdaq as TRXB on Friday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.